RhumbLine Advisers’s Apnimed Inc APMD Stock Holding History

RhumbLine Advisers’s Portfolio APMD Stock Details APMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$265K	Buy	+12,094	New	+$325K	﹤0.01%	3110

Other funds holding APMD

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13B AUM 35.88% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

RhumbLine Advisers's APMD Position: Q3 2026 in Review

RhumbLine Advisers opened a new position in Apnimed Inc (APMD) in Q3 2026: 12,094 shares worth $265K. The stake represents ﹤0.01% of the portfolio and ranks #3110 among its holdings.

20 funds tracked by Wall St. Rank hold APMD as of Q3 2026.

RhumbLine Advisers held 12,094 shares of Apnimed Inc worth $265K as of Q3 2026.
Apnimed Inc was a new RhumbLine Advisers position in Q3 2026.
Apnimed Inc made up ﹤0.01% of RhumbLine Advisers's portfolio in Q3 2026, its #3110 holding.
20 funds tracked by Wall St. Rank held Apnimed Inc as of Q3 2026.

Based on RhumbLine Advisers's 13F filing for Q3 2026, filed 10 Nov 2026.